Natural Covid – 19 remedies work better than the standard medicines

Sunday February 14, 2021 at 8:14 am

New Delhi: The makers of the two ayurvedic Covid – 19 remedies are hopeful about their treatment as they believe that these remedies work better in comparison to the standard medicines in a comparative trial.

It has been stated, “A clinical trial was conducted in India to monitor the outcome of a combination treatment for Covid. An Ayurvedic Remedy called ‘Immunofree’ by Corival Life Sciences, and a Nutraceutical called ‘Reginmune’ by Biogetica is found to work better in a comparative clinical trial against Standard of Care”.

The CEO of Wockhardt Foundation, Dr Huzaifa Khorakiwala has commented, “From the start of the pandemic we have invested in various medicines and vaccines for corona for the benefit of humanity. It is great to see natural medicine set a precedent like this at a time when the earth needs it most. We will work closely with states of India and governments around the world to make Immunofree and Reginmune the gold standard in Coronavirus treatment”.

Further adding to the statement, “Half the participants in the clinical trial for ‘Immunofree’ and ‘Reginmune’ were given these two remedies, and the other half were given the government SOP (depending on patient condition and hospital norms, which included but not limited to Paracetamol (SOS) B – complex (OD) Vitamin – C (TID), Azithromycin (OD) and Pantocid (OD).

The statement further recorded,”This herbal combination group had 88 of patients test negative on day 5, in comparison to the SOP with only 72 percent negative day 5.100 percent of patients on immunofree and reginmune tested negative day 10 and only 88 percent on the sop tested negative. Hence this study suggests that natural medicines from Ayurveda is outperforming pharmaceuticals currently being used. The groundbreaking results have been submitted to Ayush in the hope that they will expedite the approval of Immunofree and Reginmune for Covid treatment”.

“We did not have many hopes in the beginning of the trial but Immunofree even outperformed my expectations too. Remarkable results!”, stated Puneet Mittal, Research Director of Mittal Global Clinical Trial Services (MGCTS).

“It seems to us that too much expectation and emphasis is being placed on a vaccine even though the virus is rapidly mutating. The flu vaccines have been around for 70 years and it hasn’t stopped the flu. Hence, one cannot expect corona to end with a vaccine alone”, commented Dr Vijaykumar Kamat, Medical Director of Biogetica.

“Immunofree and Reginmune have now shown a result no medicine from any tradition has globally. With the entire world watching, we have shown how nature is essential in medicine. That nature has the answer when all else fails. We, therefore, hopes this opens eyes and minds, and that doctors, countries and patients who truly care about their health accept these remedies”, said Apurve Mehra, founder of Biogetica.

It has been concluded saying, “We also hope that the government lists these remedies as part of the standard of care for Covid, as they truly bear the potential of saving lives, freeing up hospital space and helping people return to normal”.